Gsk Plc-spon Adr. Earnings

Gsk Plc-spon Adr.’s revenue jumped 6.68% since last year same period to $8547Mn in the Q3 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 7.02% jump in its revenue since last 3-months.

Gsk Plc-spon Adr.’s net profit jumped 3570.69% since last year same period to $2013Mn in the Q3 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 39.5% jump in its net profits since last 3-months.

Gsk Plc-spon Adr.’s net profit margin jumped 3353.44% since last year same period to 23.55% in the Q3 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 30.34% jump in its net profit margins since last 3-months.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 0.63 - a -46.21% fall from last quarter’s estimates.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 0.63.

Gsk Plc-spon Adr.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Gsk Plc-spon Adr. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Gsk Plc-spon Adr. declared 0.42 dividend per share during the earnings announcement for Q4 2025.